The incidence of the mysterious and devastating Alzheimer's disease continues to rise in the U-S.  Justin Catanoso, Business Journal contributing writer and director of Wake Forest University's journalism program,  discusses a Triad company's new drug with potential to delay the onset of Alzheimer's.

300x250 Ad

300x250 Ad

Support quality journalism, like the story above, with your gift right now.

Donate